Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nada Albarakati
Observed names:
Al-Barakati, Nada,
Albarakati, Nada,
N Albarakati,
N. Albarakati,
Nada Albarakti
Institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Abdullah International Medical Research Center,
National Guard Health Affairs
Observed institutions:
Nottingham University Hospitals NHS Trust,
University of Nottingham,
King Saud bin Abdulaziz University for Health Sciences,
Nottingham City Hospital,
King Abdullah International Medical Research Center,
National Guard Health Affairs,
Nottingham Trent University
show all 7
ORCID:
0000-0001-5135-8684
Observed ORCID:
0000-0001-5135-8684
OpenAlex ID:
A5067744637
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
2014
·
Tarek M.A. Abdel-Fatah
, Roslin Russell
, et al.
·
Molecular Oncology
·
149
PDF
Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2012
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
·
Cancer Research
·
100
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
2013
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
·
PLoS ONE
·
84
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy
2014
·
Nada Albarakati
, Tarek M.A. Abdel-Fatah
, et al.
·
Molecular Oncology
·
79
PDF
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
2015
·
A T Alshareeda
, O H Negm
, et al.
·
British Journal of Cancer
·
72
PDF
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer
2013
·
Alaa T. Alshareeda
, Ola H. Negm
, et al.
·
Breast Cancer Research and Treatment
·
63
Circulating proteomic signature for detection of biomarkers in bladder cancer patients
2020
·
Taoufik Nedjadi
, Hicham Benabdelkamal
, et al.
·
Scientific Reports
·
44
PDF
DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts
2014
·
Tarek M.A. Abdel-Fatah
, Roslin Russell
, et al.
·
Molecular Oncology
·
35
PDF
SUMOylation proteins in breast cancer
2014
·
Alaa T. Alshareeda
, Ola H. Negm
, et al.
·
Breast Cancer Research and Treatment
·
34
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy
2013
·
Tarek M. A. Abdel-Fatah
, Nada Albarakati
, et al.
·
Breast Cancer Research and Treatment
·
34
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
2019
·
Nada Albarakati
, Dareen Khayyat
, et al.
·
BMC Cancer
·
26
PDF
Hidden regulators: the emerging roles of lncRNAs in brain development and disease
2024
·
Farah Alammari
, Ensaf M. Al-Hujaily
, et al.
·
Frontiers in Neuroscience
·
25
Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation
2021
·
Taoufik Nedjadi
, Nada Albarakati
, et al.
·
Life
·
13
PDF
Interaction between HER2 and ATM predicts poor survival in bladder cancer patients
2022
·
Nada Albarakati
, Alaa Al‐Shareeda
, et al.
·
Journal of Cellular and Molecular Medicine
·
10
Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs
2024
·
Mikhlid H. Almutairi
, Turki M. Alrubie
, et al.
·
PLoS ONE
·
7
Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
2023
·
Nada Albarakati
, Hanin Al-Ghamdi
, et al.
·
Scientific Reports
·
5
PDF
275 Targeting XRCC1 (X-ray Repair Cross-complementing Gene 1), a Key DNA Base Excision Repair Protein for Personalized Therapy in Breast and Ovarian Cancer
2012
·
R. Sultana
, T. Abdel-Fatah
, et al.
·
European Journal of Cancer
·
4
Improving the robustness and efficiency of cell sheet protocol for breast cancer induction in animal model: A Geltrex plus Gelatin approach
2025
·
Alaa T. Alshareeda
, Nada Albarakati
, et al.
·
PLoS ONE
PDF
Data from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
Supplementary Tables 1 - 4 from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
PDF
Supplementary Figures 1 - 4 from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
Supplementary Figures 1 - 4 from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
PDF
Supplementary Tables 1 - 4 from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
Data from Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy
2023
·
Rebeka Sultana
, Tarek Abdel-Fatah
, et al.
Targeting ataxia telangiectasia mutated (ATM) and DNA dependent protein kinase catalytic subunit (DNA-PKcs) for synthetic lethality application in breast cancer
2015
·
Nada Albarakati
·
Nottingham ePrints (University of Nottingham)
PDF
Show more works
View as search
Works count:
29
Citation count:
784
H-index:
13
I10-index:
14
Year
Topic
Type
